Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Cash from Operations (2017 - 2025)

Historic Cash from Operations for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $52.5 million.

  • Inspire Medical Systems' Cash from Operations fell 2415.69% to $52.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $117.0 million, marking a year-over-year decrease of 1018.84%. This contributed to the annual value of $117.0 million for FY2025, which is 1018.84% down from last year.
  • Inspire Medical Systems' Cash from Operations amounted to $52.5 million in Q4 2025, which was down 2415.69% from $68.5 million recorded in Q3 2025.
  • Inspire Medical Systems' 5-year Cash from Operations high stood at $69.2 million for Q4 2024, and its period low was -$12.7 million during Q1 2022.
  • For the 5-year period, Inspire Medical Systems' Cash from Operations averaged around $13.2 million, with its median value being $3.2 million (2023).
  • Over the last 5 years, Inspire Medical Systems' Cash from Operations had its largest YoY gain of 354102.56% in 2025, and its largest YoY loss of 17565.46% in 2025.
  • Quarter analysis of 5 years shows Inspire Medical Systems' Cash from Operations stood at $734000.0 in 2021, then skyrocketed by 2525.2% to $19.3 million in 2022, then fell by 10.39% to $17.3 million in 2023, then surged by 300.65% to $69.2 million in 2024, then dropped by 24.16% to $52.5 million in 2025.
  • Its Cash from Operations stands at $52.5 million for Q4 2025, versus $68.5 million for Q3 2025 and $2.7 million for Q2 2025.